UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in ARGX — Argenx SE

CIK 861177 NEW YORK, NY

Back to ARGX Full portfolio

Position in ARGX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$20,086,256

+$2,001,627 QoQ

Shares Held

27,506

+27.9% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

24 quarters on record

Voting authority Sole 76.95775467170799.ToString("F0")% Shared 0.ToString("F0")% None 23.04224532829201.ToString("F0")%

Common Shares in ARGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. ARGX ranks #30 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,057,396	$1,365,249,602
2	REGN	Regeneron Pharmaceuticals, Inc.	723,621	$559,098,523
3	ALNY	Alnylam Pharmaceuticals, Inc.	677,519	$224,170,706
4	INSM	INSMED Inc	1,215,025	$198,680,883
5	RPRX	Royalty Pharma plc	3,095,766	$148,503,890
6	INCY	Incyte Corp	1,540,913	$145,030,725
7	IONS	Ionis Pharmaceuticals Inc	1,475,632	$110,805,201
8	DNLI	Denali Therapeutics Inc.	4,432,314	$85,100,425

All Filings in ARGX

Export CSV

24 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$20,086,256	27,506	+27.9%	Shares	Defined	2026-05-13
2025-12-31	$18,084,629	21,505	-11.9%	Shares	Defined	2026-02-13
2025-06-30	$13,460,240	24,419	+4184.0%	Shares	Defined	2025-08-14
2025-03-31	$337,363	570	-97.2%	Shares	Defined	2025-05-19
2024-12-31	$12,561,375	20,425	-50.0%	Shares	Defined	2025-02-14
2024-09-30	$22,139,629	40,842	+4344.2%	Shares	Defined	2024-11-14
2024-06-30	$395,205	919	-97.9%	Shares	Defined	2024-08-14
2024-03-31	$17,185,877	43,650	+13.5%	Shares	Sole	2024-05-15
2023-12-31	$14,631,336	38,460	+24.3%	Shares	Sole	2024-02-14
2023-09-30	$15,208,081	30,934	-10.3%	Shares	Sole	2023-11-13
2023-06-30	$13,437,500	34,479	0.0%	Shares	Sole	2023-08-11
2023-03-31	$12,846,185	34,479	-14.1%	Shares	Sole	2023-05-15
2022-12-31	$15,207,372	40,143	+0.2%	Shares	Defined	2023-02-14
2022-09-30	$14,141,768	40,056	-13.1%	Shares	Defined	2022-11-14
2022-06-30	$17,459,925	46,083	-10.4%	Shares	Defined	2022-08-12
2022-03-31	$16,223,959	51,454	+4.4%	Shares	Defined	2022-05-16
2021-12-31	$17,265,765	49,304	-6.2%	Shares	Defined	2022-02-14
2021-09-30	$15,877,046	52,573	-3.3%	Shares	Defined	2021-11-15
2021-06-30	$16,362,551	54,348	+2.0%	Shares	Defined	2021-08-16
2021-03-31	$14,668,646	53,265	-24.0%	Shares	Defined	2021-05-14
2020-12-31	$20,614,532	70,096	+45.0%	Shares	Defined	2021-03-01
2020-09-30	$12,688,902	48,335	-10.5%	Shares	Defined	2020-11-13
2020-06-30	$12,159,715	53,988	-34.5%	Shares	Defined	2020-08-14
2020-03-31	$10,864,562	82,476	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.